Annovis Bio (ANVS) Stock Highlights

9.21 | +6.35%

2024-10-21 04:59:27

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinsons and Alzheimers diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.

Statistics

Range Today

8.55 9.3

Volume Today 275.5K

Range 1 Year

4.53 22.49

Volume 1 Year 176.01M

Range 3 Year

4.53 39.72

Volume 3 Year 213.07M

Range 10 Year

2.42 132

Volume 10 Year 426.37M

Highlights

Market Capitalization 120.23M (small)

Floating Shares 10.24M

Current Price 9.21

Price To Earnings -1.88

Earnings Per Share -4.54

Payout Ratio 0%

Performance

Latest +6.35%

1 Month +6.23%

3 Months -26.02%

6 Months +1.1%

1 Year +12.73%

3 Years -67.86%

5 Years +38.91%

10 Years +38.91%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.